Optical Imaging Workshop

Friday, September 28, 2018
8:00 a.m.-4:30 p.m.
The Hotel at the University of Maryland
cersi@umd.edu




 

 

 

 

 

You are cordially invited to attend a one-day workshop entitledTranslational Pathways for Optical Drugs and Devices for Cancer Imaging hosted by the Food and Drug Administration (FDA) in collaboration with the National Cancer Institute (NCI) and the University of Maryland Centers of Excellence in Regulatory Science and Innovation (CERSI). 

Goals and Objectives

  • To discuss regulatory expectations for the development of optical imaging drugs and devices and to identify efficient translational pathways forward.
  • To hear perspectives from industry, academia, investigators and other stakeholders on how to enhance the clinical development on optical imaging drugs and devices.

 Session Themes

  • Drug and Device Development Requirements
  • Clinical Trial Design Considerations
  • Cross Labeling / Combination Products
  • Panel and Open Forum Discussions

Attendance

Academia, investigators, device manufacturers, pharmaceutical companies, contract research organizations and government agencies are encouraged to attend.

When

September 28, 2018
8:00 am – 4:30 pm (On-site check-in begins at 7:15 am)

Where

The Hotel at the University of Maryland, 7777 Baltimore Avenue, College Park, MD 

A hotel room block with a special room rate has been made available at The Hotel at the University of Maryland. To book your stay, please contact the Hotel at (301) 277-7777 and request a room under the "Optical Imaging Workshop" room block.

Registration

Registration for both on-site and remote participation is now open.

Workshop agenda and hotel accommodations will be available soon.

 

 

September 2018

SU MO TU WE TH FR SA
26 27 28 29 30 31 1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 1 2 3 4 5 6
Submit an Event